Close
ACHEMA MIDDLE EAST 2026

Research Pins Down New Target To Get Rid of Blood Cancer

A worldwide consortium that comprises biomedical researchers co-led by Alexander Bick, MD, PhD, at the Vanderbilt University Medical Centre, has come up with a...

Customised Blood Pressure Treatment Can Get More Protection

A study from Sweden has gone on to show that patients who have been treated with drugs that are used to lower blood pressure...

Novel Therapy Uses Blood Cells of Patients To Fight Tumour

Adoptive cell therapy has gone on to become a promising immunotherapy tool that can be used to help in the treatment of advanced melanoma....

FDA Backs Randomized Controlled Trials For Speedy Drug Nods

In a significant update to its existing policies when it comes to conducting clinical trials so as to support an accelerated approval for oncology...

Sustained Release Chemotherapy, A Way Out For Bladder Cancer

As reported by a study, a novel, sustained-release chemotherapy delivery device which is inserted in the bladder has gone on to facilitate the tumour...

Cell-Energy Activity In Organs, Tissues By New MRI Method

Each cell in the body puts in considerable energy to maintain the proper balance of water and critical electrolytes in order to survive. Researchers...

Australia Sepsis Study To Aid In New Antibiotic Discovery

Researchers from the University of Queensland in Australia have led a national study pertaining to four major bacteria that cause sepsis, thereby providing new...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...